136 related articles for article (PubMed ID: 18057382)
1. Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking.
d'Herbomez M; Caron P; Bauters C; Do Cao C; Schlienger JL; Sapin R; Baldet L; Carnaille B; Wémeau JL;
Eur J Endocrinol; 2007 Dec; 157(6):749-55. PubMed ID: 18057382
[TBL] [Abstract][Full Text] [Related]
2. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.
Walter MA; Meier C; Radimerski T; Iten F; Kränzlin M; Müller-Brand J; de Groot JW; Kema IP; Links TP; Müller B
Cancer; 2010 Jan; 116(1):31-40. PubMed ID: 19890958
[TBL] [Abstract][Full Text] [Related]
4. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.
Kratzsch J; Petzold A; Raue F; Reinhardt W; Bröcker-Preuss M; Görges R; Mann K; Karges W; Morgenthaler N; Luster M; Reiners C; Thiery J; Dralle H; Fuhrer D
Clin Chem; 2011 Mar; 57(3):467-74. PubMed ID: 21159900
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin precursor levels in human medullary thyroid carcinoma.
Bihan H; Becker KL; Snider RH; Nylen E; Vittaz L; Lauret C; Modigliani E; Moretti JL; Cohen R
Thyroid; 2003 Aug; 13(8):819-22. PubMed ID: 14558925
[TBL] [Abstract][Full Text] [Related]
6. [Calcitonin, procalcitonin].
Nagasaki T; Inaba M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():295-9. PubMed ID: 16149513
[No Abstract] [Full Text] [Related]
7. Serum calcitonin reference values for calcium stimulation tests by electrochemiluminescence immunoassay in Japanese men with non-medullary thyroid carcinoma.
Kihara M; Miyauchi A; Kudo T; Hirokawa M; Miya A
Surg Today; 2018 Feb; 48(2):223-228. PubMed ID: 28821980
[TBL] [Abstract][Full Text] [Related]
8. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma.
Erdoğan MF; Güllü S; Başkal N; Uysal AR; Kamel N; Erdoğan G
J Clin Endocrinol Metab; 1997 Mar; 82(3):897-9. PubMed ID: 9062503
[TBL] [Abstract][Full Text] [Related]
10. Need for revision of diagnostic limits for medullary thyroid carcinoma with a new immunochemiluminometric calcitonin assay.
Ramachandran R; Benfield P; Dhillo WS; White S; Chapman R; Meeran K; Donaldson M; Martin NM
Clin Chem; 2009 Dec; 55(12):2225-6. PubMed ID: 19833839
[No Abstract] [Full Text] [Related]
11. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma.
Bolko P; Manuszewska-Jopek E; Michałek K; Waśko R; Jaskuła M; Sowiński J
Arch Immunol Ther Exp (Warsz); 2003; 51(6):415-9. PubMed ID: 14692663
[TBL] [Abstract][Full Text] [Related]
12. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
13. Heterophilic antibodies causing falsely high serum calcitonin values.
Papapetrou PD; Polymeris A; Karga H; Vaiopoulos G
J Endocrinol Invest; 2006 Nov; 29(10):919-23. PubMed ID: 17185902
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.
Grauer A; Raue F; Ziegler R
Exp Clin Endocrinol Diabetes; 1998; 106(4):353-9. PubMed ID: 9792470
[TBL] [Abstract][Full Text] [Related]
15. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis.
Grani G; Nesca A; Del Sordo M; Calvanese A; Carbotta G; Bianchini M; Fumarola A
Endocr Relat Cancer; 2012 Jun; 19(3):345-9. PubMed ID: 22399011
[TBL] [Abstract][Full Text] [Related]
17. Performance evaluation of an automated electrochemiluminescent calcitonin (CT) immunoassay in diagnosis of medullary thyroid carcinoma.
Schiettecatte J; Strasser O; Anckaert E; Smitz J
Clin Biochem; 2016 Aug; 49(12):929-31. PubMed ID: 27182955
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
[TBL] [Abstract][Full Text] [Related]
19. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
[TBL] [Abstract][Full Text] [Related]
20. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
